These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

100 related items for PubMed ID: 3574223

  • 1. Misleading advertising.
    Bridge DT.
    Med J Aust; 1987 Feb 16; 146(4):229-30. PubMed ID: 3574223
    [No Abstract] [Full Text] [Related]

  • 2. [Advances in hormonal contraception. A new micro-pll with especially low hormone effect].
    Gynakologe; 1994 Apr 16; 27(2 Suppl):1-12. PubMed ID: 9131064
    [No Abstract] [Full Text] [Related]

  • 3. [Effects of hormonal contraceptives on menstrual and reproductive function of women].
    Dubnitskaia LV, Sotnikova EI.
    Akush Ginekol (Mosk); 1990 Apr 16; (4):57-60. PubMed ID: 1696071
    [Abstract] [Full Text] [Related]

  • 4. Oral contraception, 1986. Currently available formulations.
    Hale R.
    J Reprod Med; 1986 Jun 16; 31(6 Suppl):557-8. PubMed ID: 3088272
    [Abstract] [Full Text] [Related]

  • 5. Oral contraception with a biphasic tablet (observations with anteovin).
    Tallián F.
    Ther Hung; 1986 Jun 16; 34(2):112-6. PubMed ID: 3449970
    [No Abstract] [Full Text] [Related]

  • 6. Use of biphasic cyclic hormone therapy in functional bleeding disorders of adolescents (Anteovin).
    Kis-Csitári I.
    Ther Hung; 1988 Jun 16; 36(2):73-6. PubMed ID: 3201389
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. A two-year clinical study of the effects of two triphasic oral contraceptives on plasma lipids.
    Kakis G, Powell M, Marshall A, Woutersz TB, Steiner G.
    Int J Fertil Menopausal Stud; 1994 Jun 16; 39(5):283-91. PubMed ID: 7820162
    [Abstract] [Full Text] [Related]

  • 10. [Use of Ovidon, Rigevidon and Postinor for contraception].
    Kulakov VI, Barinov AM, Prilepskaia VN.
    Akush Ginekol (Mosk); 1983 Nov 16; (11):22-4. PubMed ID: 6666791
    [No Abstract] [Full Text] [Related]

  • 11. Scheduled and unscheduled bleeding patterns with two combined hormonal contraceptives: application of new recommendations for standardization.
    Hampton RM, Fisher AC, Pagano S, LaGuardia KD.
    Fertil Steril; 2009 Aug 16; 92(2):434-40. PubMed ID: 18930189
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Confusion between oral contraceptives and oestrogen replacement preparations.
    Levinsohn DG.
    S Afr Med J; 1988 Jul 16; 74(2):89. PubMed ID: 3399985
    [No Abstract] [Full Text] [Related]

  • 15. [Oral contraceptives: 30 vs 20 micrograms of ethinyl estradiol (EE)].
    Urdinola J.
    Adv Contracept; 1994 Jul 16; 10 Suppl 1():41-9. PubMed ID: 7839871
    [No Abstract] [Full Text] [Related]

  • 16. "Estrophasic" dosing: A new concept in oral contraceptive therapy.
    Rowan JP.
    Am J Obstet Gynecol; 1999 Feb 16; 180(2 Pt 2):302-6. PubMed ID: 9988834
    [Abstract] [Full Text] [Related]

  • 17. [Low dose p-pills, Gynatrol and Mikrogyn].
    Falck Larsen J.
    Ugeskr Laeger; 1976 Sep 27; 138(40):2446-7. PubMed ID: 969002
    [No Abstract] [Full Text] [Related]

  • 18. Use of triphasic Tri-Regol tablet in women of borderline age.
    Takács G.
    Ther Hung; 1991 Sep 27; 39(4):188-91. PubMed ID: 1811332
    [Abstract] [Full Text] [Related]

  • 19. Alopecia related to low dose oral contraceptive.
    Yokoyama Y, Sato S, Saito Y.
    Arch Gynecol Obstet; 2002 Jan 27; 266(1):46-7. PubMed ID: 11998965
    [Abstract] [Full Text] [Related]

  • 20. Development of the ratio of levonorgestrel, 0.15 mg, to ethinyl estradiol, 0.03 mg.
    Christie T.
    J Reprod Med; 1983 Jan 27; 28(1 Suppl):63-5. PubMed ID: 6403701
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.